Skip to main content
SpringerLink
Log in

NICE has recommended the use of rivaroxaban [Xarelto], a new oral anticoagulant

  • Media release
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. The National Institute for Health and Clinical Excellence (NICE).NICE Recommends Xarelto(R) (Rivaroxaban) Use in NHS. Media Release: 5 Mar 2009. Available from: URL: http://www.nice.org.uk

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

NICE has recommended the use of rivaroxaban [Xarelto], a new oral anticoagulant. Pharmacoecon. Outcomes News 574, 3 (2009). https://doi.org/10.2165/00151234-200905740-00007

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-200905740-00007

Keywords

Search

Navigation